/Companies

Hemovent

acquired by Microport

6 known investors

Find your way into Hemovent

Hemovent develops the MobyBox, a pneumatically driven extracorporeal membrane oxygenation (ECMO) system, including a low-resistance high-performance oxygenator. The device is used for respiratory and cardiac support, including cases of COVID-19-associated adult respiratory distress syndrome.

Investors · 6

Also in the syndicate · 3

KfW-BankMIG-InvestmentfondsNRW-Bank

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Hemovent do?
Hemovent develops the MobyBox, a pneumatically driven extracorporeal membrane oxygenation (ECMO) system, including a low-resistance high-performance oxygenator. The device is used for respiratory and cardiac support, including cases of COVID-19-associated adult respiratory distress syndrome.
Who are Hemovent's investors?
Hemovent's investors include MIG Capital AG, TechVision Fonds, Seed Fonds Aachen.
Who acquired Hemovent?
Hemovent was acquired by Microport.